This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We are grateful for the interest in our article on the treatment effect of alteplase in acute ischemic stroke patients with preexisting cerebral microbleeds (CMBs).1 The readers point out that new lesions are observed on susceptibility-weighted imaging (SWI) in patients with artificial heart valves that meet the imaging criteria of CMBs and suggest that these lesions should be differentiated from CMBs associated with small vessel disease to better identify patients with an increased bleeding risk.2 Of interest, a previous study showed that new CMBs occurring in acute ischemic stroke patients after receiving IV thrombolysis (IVT) were indeed associated with an increased risk of IVT-related hemorrhagic complications.3 On the other hand, new CMBs were not associated with an increased risk of bleeding in patients undergoing cardiac surgery.2,4 However, IVT may constitute a different bleeding risk than cardiopulmonary bypass and extracorporeal membrane oxygenation, or a prolonged intensive care unit stay. The question of whether CMBs in patients with artificial heart valves represent a different pathophysiologic entity with a different bleeding risk merits further research and would profit from histopathology studies and observational studies in stroke and nonstroke cohorts with long-term follow-up.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
